Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks

被引:22
|
作者
El-Gamal, Mohamed [1 ,2 ]
Salama, Mohamed [1 ,2 ,3 ]
Collins-Praino, Lyndsey E. [4 ]
Baetu, Irina [4 ]
Fathalla, Ahmed M. [5 ]
Soliman, Amira M. [5 ]
Mohamed, Wael [6 ,7 ]
Moustafa, Ahmed A. [8 ,9 ,10 ]
机构
[1] Mansoura Univ, Toxicol Dept, Fac Med, Mansoura, Egypt
[2] Mansoura Univ, Med Expt Res Ctr MERC, Fac Med, Mansoura, Egypt
[3] Trinity Coll Dublin TCD, Global Brain Hlth Inst GBHI, Dublin, Ireland
[4] Univ Adelaide, Adelaide, SA, Australia
[5] Suez Canal Univ, Dept Pharmacol, Fac Med, Ismailia, Egypt
[6] Menoufia Univ, Clin Pharmacol Dept, Fac Med, Mansoura, Egypt
[7] Int Islamic Univ, Dept Basic Med Sci, Kulliyyah Med, Kuantan, Pahang, Malaysia
[8] Western Sydney Univ, Sch Social Sci & Psychol, Sydney, NSW, Australia
[9] Western Sydney Univ, Marcs Inst Brain & Behav, Sydney, NSW, Australia
[10] Univ Johannesburg, Dept Human Anat & Physiol, Fac Hlth Sci, Johannesburg, South Africa
关键词
Parkinsonian; Toxins; Pesticides; Dopamine; Animal models; Epigenetics;
D O I
10.1007/s12640-021-00356-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD), the second most common neurodegenerative disorder, is characterized by cardinal motor impairments, including akinesia and tremor, as well as by a host of non-motor symptoms, including both autonomic and cognitive dysfunction. PD is associated with a death of nigral dopaminergic neurons, as well as the pathological spread of Lewy bodies, consisting predominantly of the misfolded protein alpha-synuclein. To date, only symptomatic treatments, such as levodopa, are available, and trials aiming to cure the disease, or at least halt its progression, have not been successful. Wong et al. (2019) suggested that the lack of effective therapy against neurodegeneration in PD might be attributed to the fact that the molecular mechanisms standing behind the dopaminergic neuronal vulnerability are still a major scientific challenge. Understanding these molecular mechanisms is critical for developing effective therapy. Thirty-five years ago, Calne and William Langston (1983) raised the question of whether biological or environmental factors precipitate the development of PD. In spite of great advances in technology and medicine, this question still lacks a clear answer. Only 5-15% of PD cases are attributed to a genetic mutation, with the majority of cases classified as idiopathic, which could be linked to exposure to environmental contaminants. Rodent models play a crucial role in understanding the risk factors and pathogenesis of PD. Additionally, well-validated rodent models are critical for driving the preclinical development of clinically translatable treatment options. In this review, we discuss the mechanisms, similarities and differences, as well as advantages and limitations of different neurotoxin-induced rat models of PD. In the second part of this review, we will discuss the potential future of neurotoxin-induced models of PD. Finally, we will briefly demonstrate the crucial role of gene-environment interactions in PD and discuss fusion or dual PD models. We argue that these models have the potential to significantly further our understanding of PD.
引用
收藏
页码:897 / 923
页数:27
相关论文
共 50 条
  • [1] Neurotoxin-Induced Rodent Models of Parkinson’s Disease: Benefits and Drawbacks
    Mohamed El-Gamal
    Mohamed Salama
    Lyndsey E. Collins-Praino
    Irina Baetu
    Ahmed M. Fathalla
    Amira M. Soliman
    Wael Mohamed
    Ahmed A. Moustafa
    Neurotoxicity Research, 2021, 39 : 897 - 923
  • [2] Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson's Disease
    Prasad, E. Maruthi
    Hung, Shih-Ya
    ANTIOXIDANTS, 2020, 9 (10) : 1 - 50
  • [3] Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease
    Hironori Yokoyama
    Hiroto Uchida
    Hayato Kuroiwa
    Jiro Kasahara
    Tsutomu Araki
    Neurological Sciences, 2011, 32 : 1 - 7
  • [4] Role of glial cells in neurotoxin-induced animal models of Parkinson's disease
    Yokoyama, Hironori
    Uchida, Hiroto
    Kuroiwa, Hayato
    Kasahara, Jiro
    Araki, Tsutomu
    NEUROLOGICAL SCIENCES, 2011, 32 (01) : 1 - 7
  • [5] Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment
    Zeng, Xian-Si
    Geng, Wen-Shuo
    Jia, Jin-Jing
    ASN NEURO, 2018, 10
  • [6] Neurogenesis in Neurotoxin-induced Animal Models for Parkinson's Disease-A Review of the Current Status
    He, Xi Jun
    Nakayama, Hiroyuki
    JOURNAL OF TOXICOLOGIC PATHOLOGY, 2009, 22 (02) : 101 - 108
  • [7] Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson's Disease
    Zhao, Xin
    Zhai, Shenyu
    An, Ming-Sheng
    Wang, Yue-Hua
    Yang, Ying-Fan
    Ge, Hui-Qi
    Liu, Jin-Hao
    Pu, Xiao-Ping
    PLOS ONE, 2013, 8 (10):
  • [8] Reduced Levels of Intestinal Neuropeptides and Neurotrophins in Neurotoxin-Induced Parkinson Disease Mouse Models
    Choi, Jin Gyu
    Jeong, Miran
    Joo, Boh Rah
    Ahn, Ji-Hye
    Woo, Jeong-Hwa
    Kim, Dong-Hyun
    Oh, Myung Sook
    Choi, Jung-Hye
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (01): : 15 - 20
  • [9] Neuroprotection effects of retained acupuncture in neurotoxin-induced Parkinson's disease mice
    Yang, Jen-Lin
    Chen, Jay S. C.
    Yang, Yi-Fei
    Chen, Jyh-Cheng
    Lin, Ching-Huang
    Chang, Rong-Seng
    Tsao, Po-Jui
    Chen, Fang-Pey
    Chern, Chang-Ming
    Tsai, Tung-Hu
    Chiu, Jen-Hwey
    BRAIN BEHAVIOR AND IMMUNITY, 2011, 25 (07) : 1452 - 1459
  • [10] Application of Neurotoxin-Induced Animal Models in the Study of Parkinson's Disease-Related Depression: Profile and Proposal
    Mou, Ya-Kui
    Guan, Li-Na
    Yao, Xiao-Yan
    Wang, Jia-Hui
    Song, Xiao-Yu
    Ji, Yong-Qiang
    Ren, Chao
    Wei, Shi-Zhuang
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14